Aceto Co. (NASDAQ:ACET) gapped down prior to trading on Thursday . The stock had previously closed at $0.22, but opened at $0.20. Aceto shares last traded at $0.19, with a volume of 3042055 shares changing hands.

The company has a debt-to-equity ratio of 2.65, a quick ratio of 0.64 and a current ratio of 1.00.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Pacer Advisors Inc. boosted its position in Aceto by 237.3% during the 3rd quarter. Pacer Advisors Inc. now owns 50,838 shares of the company’s stock valued at $115,000 after purchasing an additional 35,766 shares during the period. California Public Employees Retirement System boosted its position in Aceto by 13.9% during the 4th quarter. California Public Employees Retirement System now owns 166,883 shares of the company’s stock valued at $140,000 after purchasing an additional 20,333 shares during the period. D. E. Shaw & Co. Inc. boosted its position in Aceto by 1,650.2% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 206,525 shares of the company’s stock valued at $174,000 after purchasing an additional 194,725 shares during the period. Two Sigma Advisers LP boosted its position in Aceto by 34.0% during the 4th quarter. Two Sigma Advisers LP now owns 282,741 shares of the company’s stock valued at $238,000 after purchasing an additional 71,787 shares during the period. Finally, Geode Capital Management LLC boosted its position in Aceto by 41.7% during the 4th quarter. Geode Capital Management LLC now owns 318,513 shares of the company’s stock valued at $267,000 after purchasing an additional 93,808 shares during the period. Institutional investors and hedge funds own 35.78% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Aceto (ACET) Shares Gap Down to $0.20” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://theolympiareport.com/2019/03/14/aceto-acet-shares-gap-down-to-0-20.html.

Aceto Company Profile (NASDAQ:ACET)

Aceto Corporation engages in the development, marketing, sale, and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals, and agricultural protection products. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals.

Read More: SEC Filing

Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.